Rayner to Launch RayOne EMV Enhanced Monofocal IOL

Rayner has announced the upcoming European launch of RayOne EMV, a new fully preloaded non-diffractive IOL designed to enhance patient outcomes achieved with monovision.

Developed in collaboration with Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons, RayOne EMV extends a patient’s range of vision with a patented non-diffractive aspheric optic profile, designed to:

• Provide up to 2.25 D of extended depth of vision (with 1.0 D offset)
• Provide superior intermediate vision when compared with standard monofocals
• Reduce dysphotopsia compared to diffractive multifocal and EDOF IOL designs
• Provide a smoother, blended transition between the dominant and non-dominant eyes when compared with standard monofocals, maintaining binocular stereoacuity and reducing asthenopia

“For many years I have worked on optimizing a lens for monovision, given that it accounts for nearly 30% of all surgeries. I collaborated with Rayner on bringing this lens to market as RayOne EMV, an exciting new product for all surgeons looking to treat presbyopia reliably,” Professor Barrett said in a Rayner news release.

Following CE mark approval earlier this year, Rayner conducted a multi-surgeon, multisite evaluation of the new RayOne EMV IOL across Portugal, Spain, and the UK. The company said surgeons performing first-in-eye implantations reported high levels of satisfaction with RayOne EMV performance.

Visual acuity data indicated favorable results at both distance and intermediate at 1 month. Uncorrected bilateral distance visual acuity was reported as -0.08 ± 0.09 and intermediate -0.05 ± 0.17.  Patients implanted with RayOne EMV were highly satisfied with their postoperative refractive outcomes and were dysphotopsia-free.

“RayOne EMV was created specifically for surgeons who currently utilize standard monofocal IOLs to achieve monovision but would like to see better intermediate visual outcomes without increasing the frequency of challenges experienced with other premium IOLs such as dysphotopsia and patient affordability,” Rayner CEO Tim Clover said in the news release.

RayOne EMV is the latest in Rayner’s pipeline of presbyopia-correcting solutions, adding to their portfolio of trifocal capsular bag and pseudophakic supplementary IOLs. RayOne EMV expands Rayner’s fully preloaded RayOne IOL platform, used in over 1.5 million cataract procedures since its 2016 launch.

Patient outcomes for RayOne EMV can be tracked using RayPRO: a free contactless telehealth solution that collects 3 years worth of Patient Reported Outcomes after cataract or refractive surgery.

The RayOne EMV will be launched on October 2, 2020, in approved European markets. It is not yet available in the United States.

Surgeons are invited to join ‘Presbyopia correction: It’s time to rethink monovision’ on September 29 at 19:30 (UK)/20:30 (Spain). Register here:  http://bitly.ws/9KCH